CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
LIVIMODE develops non-invasive imaging tools to visualize disease-related molecular events using optical imaging. The project focuses on creating selective SMART probes for monitoring diseases like cancer and osteoarthritis, enhancing disease detection and therapy evaluation.
LIVIMODE aims to develop specific tools for non invasive in vivo imaging of disease related molecular events.
Such tools are of high relevance for disease detection, staging, developing animal models of human disease, and evaluating novel therapies.
We propose to use optical imaging, which is optimally suited for this task as it provides excellent sensitivity and allows visualizing molecular events via a fluorescent signal.
While optical imaging technology has rapidly evolved over the last years…
INSTITUT JOZEF STEFAN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, ZURICH
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Cerdanyola Del Valles
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom, LONDON
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
SANOFI-AVENTIS DEUTSCHLAND GMBH
Germany, Frankfurt Am Main
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
